-+ 0.00%
-+ 0.00%
-+ 0.00%

TYRA BIOSCIENCES SHARES DOWN 26.1% AFTER CANCER DRUG MISSES WALL STREET EXPECTATIONS

Reuters·09/09/2026 13:42:35

Please log in to view news